Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito^®) in Korean adults with hypertension and hypercholesterolemia

References

• PerkJDe BackerGGohlkeHEuropean guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Eur Heart J201233131635170122555213
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
   PubMed Web of Science ®Google Scholar
• HurtubiseJMcLellanKDurrKOnasanyaONwabukoDNdisangJFThe different facets of dyslipidemia and hypertension in atherosclerosisCurr Atheroscler Rep201618128227822682
   PubMed Web of Science ®Google Scholar
• ThomasFBeanKGuizeLQuentzelSArgyriadisPBenetosACombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and womenEur Heart J200223752853511922642
   PubMed Web of Science ®Google Scholar
• SatohMOhkuboTAsayamaKCombined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: evidence for cardiovascular prevention from observational cohorts in JapanHypertension201565351752425601929
   PubMed Web of Science ®Google Scholar
• WongNDLopezVTangSWilliamsGRPrevalenceWGRPrevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United StatesAm J Cardiol200698220420816828593
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 reportJAMA2003289192560257212748199
   PubMed Web of Science ®Google Scholar
• WongNDLopezVAL’ItalienGChenRKlineSEFranklinSSInadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003–2004Arch Intern Med2007167222431243618071164
   PubMedGoogle Scholar
• PetrellaRJMerikleEA retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in southwestern Ontario, CanadaClin Ther20083061145115418640470
   PubMed Web of Science ®Google Scholar
• BangaloreSKamalakkannanGParkarSMesserliFHFixed-dose combinations improve medication compliance: a meta-analysisAm J Med2007120871371917679131
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC guidelines for the management of arterial hypertension: the task Force for the management of arterial hypertension of the European Society of hypertension (ESH) and of the European Society of cardiology (ESC)J Hypertens20133171281135723817082
   PubMed Web of Science ®Google Scholar
• NeutelJMBestermannWHDyessEMThe use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter studyJ Clin Hypertens20091112230
   Web of Science ®Google Scholar
• MatcharDBMcCroryDCOrlandoLASystematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertensionAnn Intern Med20081481162917984484
   PubMed Web of Science ®Google Scholar
• BorghiCCiceroAFThe role of irbesartan in the treatment of patients with hypertension: a comprehensive and practical reviewHigh Blood Press Cardiovasc Prev2012191193122670584
   PubMedGoogle Scholar
• HyreADMuntnerPMenkeARaggiPHeJTrends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adultsAnn Epidemiol200717754855517395483
   PubMed Web of Science ®Google Scholar
• BlankRLasalleJReevesRMaroniJTarasenkoLSunFSingle-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin GEMINI study)J Clin Hypertens200575264273
   Google Scholar
• BrintonEAEffects of ethanol intake on lipoproteinsCurr Atheroscler Rep201214210811422350634
   PubMed Web of Science ®Google Scholar
• The West of Scotland Coronary Prevention Study GroupCompliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention studyEur Heart J19971811171817249402445
   PubMed Web of Science ®Google Scholar
• HalpernMTKhanZMSchmierJKRecommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataHypertension20064761039104816651464
   PubMed Web of Science ®Google Scholar
• JackeviciusCAMamdaniMTuJVAdherence with statin therapy in elderly patients with and without acute coronary syndromesJAMA2002288446246712132976
   PubMed Web of Science ®Google Scholar
• MaJVaillancourtRBennettCAdherence to lipid-lowering drug therapy among members of the Canadian forcesMil Med2008173766667018700601
   PubMed Web of Science ®Google Scholar
• DresserGKNelsonSAMahonJLSimplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2)J Hypertens20133181702171323743804
   PubMed Web of Science ®Google Scholar
• FedackoJPellaDJarcuskaPSlovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the strong duet study)Adv Ther2013301607023328937
   PubMed Web of Science ®Google Scholar
• KimSHJoSHLeeSCBlood pressure and cholesterol-lowering efficacy of a fixed-dose combination with irbesartan and atorvastatin in patients with hypertension and hypercholesterolemia: a randomized, double-blind, factorial, multicenter phase III studyClin Ther201638102171218427742464
   PubMed Web of Science ®Google Scholar